Lupus: Symptoms, Types, Diagnosis and Treatment
Updated
Lupus is a long-term autoimmune disease in which the immune system attacks the body's own tissues, causing inflammation that can affect the skin, joints, kidneys, blood cells, heart, lungs and brain. The most common form is systemic lupus erythematosus (SLE); the others are cutaneous lupus, which mainly affects the skin, drug-induced lupus and neonatal lupus. Lupus mostly affects women between their teens and their forties, and its symptoms, such as extreme tiredness, joint pain, a butterfly-shaped rash across the cheeks and nose, sensitivity to sunlight, mouth ulcers and fever, tend to come and go in flares. There is no single test for it: doctors combine symptoms, an examination and blood and urine tests. This guide covers the types, who gets lupus, the symptoms and organs involved, flares, how it is diagnosed, how it is treated, pregnancy and when to get urgent care. It follows the 2019 EULAR/ACR criteria and the EULAR 2023 recommendations, and every figure links to its source.
- Main symptomsFatigue, joint pain or swelling, butterfly rash, sun sensitivity, mouth ulcers, fever, hair loss
- Who gets itAbout 9 in 10 people with lupus are women, most aged 15 to 44 at onset (Lupus Foundation of America)
- First testAntinuclear antibodies (ANA); nearly everyone with lupus tests positive, but so do many healthy people
- TreatmentHydroxychloroquine for all patients (EULAR 2023), plus steroids, immunosuppressants or biologics as needed
What is lupus, and what are its types?
Lupus is an autoimmune disease: the immune system, which normally fights infection, makes antibodies and immune cells that attack healthy tissue, causing inflammation and, over time, damage to organs. MedlinePlus describes four main types. Systemic lupus erythematosus (SLE) is the most common and the one most people mean when they say lupus; it can be mild or severe and can affect many parts of the body. Cutaneous lupus affects the skin, often with a rash or sores after sun exposure, and its two major forms are discoid lupus and subacute cutaneous lupus. Drug-induced lupus is a reaction to certain medicines, and its symptoms usually go away once the medicine is stopped. Neonatal lupus is rare: it affects newborns and is caused by antibodies that pass from the mother to the baby before birth. The Lupus Foundation of America estimates that systemic lupus makes up about 70% of cases, and cutaneous and drug-induced lupus about 10% each. Lupus is not contagious.
- Systemic lupus erythematosus (SLE): the whole-body form, which can involve the skin, joints, kidneys, blood, heart, lungs and nervous system. Most of this guide is about SLE.
- Cutaneous lupus: discoid lupus causes red to purple patches that can leave scars and patchy colour changes and, on the scalp, scarring hair loss; subacute cutaneous lupus causes ring-shaped or scaly patches, usually on sun-exposed skin, as the 2019 criteria define them.
- Drug-induced lupus: MedlinePlus names isoniazid, hydralazine, procainamide, TNF inhibitors, minocycline and quinidine as the medicines most often involved. Symptoms tend to start after at least 3 to 6 months on the drug, are usually milder than SLE, and often go away within days to weeks of stopping it. Never stop a prescribed medicine without talking to your doctor.
- Neonatal lupus: the most common sign is a rash on the baby's face that usually fades within 6 months. It is not the same as adult lupus and does not mean the child will develop lupus later, according to the Lupus Foundation of America. Its rare serious form, congenital heart block, is covered under pregnancy below.
Who gets lupus?
Lupus mostly affects women of childbearing age, and it is more common, and often more severe, in some ethnic groups. The Lupus Foundation of America says about 90% of people with lupus are women and that most develop it between the ages of 15 and 44, while the American College of Rheumatology notes that about 20% of people with SLE first develop it as children or teenagers. The most careful US count comes from a 2021 meta-analysis of the CDC's National Lupus Registry network, which estimated that 204,295 people in the United States met the classification criteria for SLE in 2018, a prevalence of 72.8 per 100,000. In that study SLE was 9 times more common in females than in males (128.7 versus 14.6 per 100,000). Among women, rates were highest in American Indian and Alaska Native women (270.6 per 100,000) and Black women (230.9), followed by Hispanic (120.7), White (84.7) and Asian or Pacific Islander women (84.4).
The Lupus Foundation of America gives a larger estimate of 1.5 million Americans living with lupus, because it counts every type of lupus rather than only people who meet the research criteria for SLE. MedlinePlus adds that African American and Hispanic women are more likely to have severe forms. The cause is not fully understood. Genes play a part: the Lupus Foundation of America says about 20% of people with lupus have a parent or sibling who has lupus or may develop it, and about 5% of children born to people with lupus develop it, but the CDC points out that most people with lupus have no relative with the disease. The NHS lists viral infections, certain medicines, sunlight, puberty, childbirth and the menopause among the possible triggers.
What are the symptoms of lupus?
The symptoms of lupus vary a great deal from person to person, range from mild to life-threatening, and often come and go, which is one reason the disease is hard to recognize. The CDC names fatigue as the most common symptom, and the NHS describes it as extreme tiredness that does not go away however much you rest. The other common symptoms, according to the CDC, are pain or swelling in the muscles and joints, skin rashes, including a butterfly-shaped rash across the cheeks and the bridge of the nose, fever, hair loss and frequent mouth sores. MedlinePlus adds morning stiffness in swollen joints, sensitivity to sunlight, swollen glands, swelling of the legs or around the eyes, and Raynaud phenomenon, in which the fingers and toes turn pale or purple in the cold. Because SLE can involve internal organs, some of the most important signs are found on blood and urine tests rather than felt.
Kidneys: lupus nephritis
Kidney inflammation, called lupus nephritis, is one of the most serious parts of SLE. The US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) says that as many as 5 in 10 adults with lupus and 8 in 10 children with lupus will have kidney disease, and that 10 to 30 percent of people with lupus nephritis go on to kidney failure. Warning signs are foamy urine, swelling of the legs, feet or ankles, and high blood pressure, but these are easy to miss, so lupus nephritis is usually found with urine tests for protein and blood and a blood creatinine test, the number used to estimate kidney function (see the eGFR calculator). A kidney biopsy confirms the diagnosis and its class, which guides treatment.
Blood
Lupus can lower the white cell count (below 4,000/mm³ in the 2019 criteria), the platelet count (below 100,000/mm³) or the red cells, when antibodies destroy them in autoimmune hemolytic anemia; the CDC also lists anemia among the problems lupus can cause (see our guide to anemia). The American College of Rheumatology notes a higher risk of blood clots, linked especially to antiphospholipid antibodies.
Heart and lungs
Inflammation of the lining around the heart (pericarditis) or the lungs (pleurisy) causes sharp chest pain that is worse on a deep breath, and fluid can collect around either organ. Lupus can also affect the heart muscle and the lungs themselves, and the EULAR 2023 recommendations include protecting the heart and blood vessels as part of long-term care.
Brain and nerves
MedlinePlus lists headache, dizziness, confusion and memory problems, and the CDC adds mental health conditions and memory changes. Less often, lupus causes seizures, psychosis or delirium, all of which appear in the 2019 criteria. Eye damage can also occur.
What triggers a lupus flare?
A lupus flare is a period when symptoms get worse, and the CDC describes flares as coming and going in waves, sometimes years apart, with periods of remission in between, when symptoms temporarily go away; some people flare often, and the NHS notes that others have symptoms all the time. A flare can last a few weeks or longer before it settles, and the NHS says its exact cause is often unknown. Some triggers are well recognized, though. The American College of Rheumatology warns that sunlight can trigger flares, and the Lupus Foundation of America lists ultraviolet light, infections such as Epstein-Barr virus, certain medicines, emotional stress, lack of sleep, smoking and some hormone medicines, such as birth control pills and hormone replacement therapy, among the environmental factors linked to lupus. The NHS adds that stress can make symptoms worse and that smoking worsens lupus. Stopping treatment matters too: the CDC lists not following a treatment plan as a factor that makes lupus worse.
- Sunlight and UV light: the most familiar trigger for both skin and whole-body symptoms; the NHS also advises avoiding long periods under fluorescent lights.
- Infections: they can set off a flare, and they are also more likely when the immune system is suppressed by treatment.
- Stress and poor sleep: both are on the Lupus Foundation of America list, and pacing yourself is part of NHS self-care advice.
- Medicines: stopping lupus medicines, or starting certain other drugs or hormone treatments, is worth discussing with your rheumatologist first.
Not everyone has the same triggers, so the Lupus Foundation of America suggests keeping track of symptoms, illnesses, injuries and stress to spot your own pattern. Kidney problems are mostly found through tests rather than felt, which is why the NHS describes regular urine tests once lupus is confirmed, even when you feel well.
How is lupus diagnosed?
Lupus is diagnosed by a doctor, usually a rheumatologist, who puts together the symptoms, a physical examination and a set of blood and urine tests, because, as the CDC and MedlinePlus both stress, there is no single test for lupus. The usual entry test is antinuclear antibodies (ANA). Almost everyone with lupus has a positive ANA: in the systematic review behind the 2019 EULAR/ACR criteria, an ANA of at least 1:80 on HEp-2 cells had a sensitivity of 97.8%, so a negative ANA makes SLE unlikely. A positive ANA on its own does not mean lupus, though. In a US national survey of 4,754 people (Satoh et al., 2012), 13.8% of everyone aged 12 and older had a positive ANA, which suggests more than 32 million people in the United States. That is why a positive ANA is followed by more specific antibody tests and why diagnosis can take time: the Lupus Foundation of America reports an average of nearly six years.
The other blood and urine tests
- Anti-dsDNA and anti-Smith (anti-Sm) antibodies: much more specific for SLE than ANA; the 2019 criteria count anti-dsDNA only from an assay with at least 90% specificity for SLE.
- Complement proteins C3 and C4: low levels can signal active disease, and the American College of Rheumatology notes that regular blood tests track these markers of activity.
- Antiphospholipid antibodies: anticardiolipin, anti-beta-2 glycoprotein I and lupus anticoagulant, which are linked to blood clots and pregnancy problems.
- Full blood count: looks for low white cells, platelets or red cells.
- Urine and kidney tests: a urine test for protein and blood, a urine protein-to-creatinine ratio, and blood creatinine. A kidney or skin biopsy may follow.
The 2019 EULAR/ACR criteria in plain words
The 2019 criteria from EULAR and the American College of Rheumatology (ACR) work like a points system. A positive ANA of at least 1:80, at least once, is the entry ticket. Findings are then scored in 7 clinical domains (fever, blood, nerves and brain, skin and mouth, linings of the heart and lungs, joints and kidneys) and 3 immunology domains (antiphospholipid antibodies, complement and SLE-specific antibodies), with weights from 2 to 10. Only the highest-scoring item in each domain counts, an item counts only if nothing explains it better, and it is enough for a finding to have occurred once. A total of 10 points or more classifies SLE. In the validation cohort the criteria had a sensitivity of 96.1% and a specificity of 93.4%. The authors stress that these are classification criteria for research, not a diagnostic checklist: a person who scores under 10 can still have lupus and be treated for it.
Test results are where many people get stuck. A positive ANA with no diagnosis, a borderline anti-dsDNA, or a report that lists C3 and C4 without saying what they mean can leave you with more questions than answers before your appointment. AskMed is a medical question app made for doctors, nurses, pharmacists, medical students and researchers. Instead of answering from memory, it searches journals, clinical guidelines and drug labels first, then writes an answer with a link after every claim. Ask it what a positive ANA of 1:160 with a negative anti-dsDNA and normal complement usually means, and which findings would point toward or away from lupus, and the answer sets out what the 2019 criteria and the studies behind them say, with each source one tap away, so you can go through it with your rheumatologist.
Ask AskMed what your ANA and antibody results mean:
How is lupus treated?
Lupus treatment aims to control inflammation, prevent flares and organ damage, and keep steroid use as low as possible, and the EULAR 2023 recommendations build it in layers. Hydroxychloroquine, an antimalarial medicine, is the cornerstone: EULAR recommends it for all patients with lupus, balancing each person's risk of flares against the risk of eye toxicity. Glucocorticoids (steroids such as prednisone) act quickly and are used as a bridge while the disease is active, then reduced to the lowest possible level and, when possible, stopped. When hydroxychloroquine alone is not enough, or steroids cannot be lowered, EULAR advises starting an immunosuppressant (methotrexate, azathioprine or mycophenolate) and/or a biologic (anifrolumab or belimumab) promptly. Cyclophosphamide is kept for organ-threatening disease and rituximab for disease that does not respond. Anti-inflammatory painkillers such as ibuprofen can help joint pain, according to the NHS. Treatment depends on which organs are involved and how active the disease is, so it changes over time.
Biologics: belimumab and anifrolumab
Belimumab (Benlysta) blocks B-lymphocyte stimulator (BLyS), a protein that helps antibody-making B cells survive. Its FDA label covers active SLE and active lupus nephritis in people aged 5 and older who are already on standard therapy. Anifrolumab (Saphnelo) blocks the type I interferon receptor; its label notes that about 60 to 80% of adults with active SLE show raised activity of interferon-driven genes. It is approved for adults with moderate to severe SLE on standard therapy, but it has not been studied in, and is not recommended for, severe active lupus nephritis or severe active lupus of the brain and nerves.
Treating lupus nephritis
For active lupus nephritis, EULAR 2023 uses steroids with mycophenolate or intravenous cyclophosphamide as the anchor treatment, and suggests adding belimumab or a calcineurin inhibitor (voclosporin or tacrolimus). Blood pressure control and kidney-protecting medicines are part of care too, and NIDDK lists ACE inhibitors and ARBs among them.
Hydroxychloroquine and your eyes
Hydroxychloroquine can, rarely, damage the retina after years of use. The American Academy of Ophthalmology (2016) puts the risk at recommended use under 1% for the first 5 years and under 2% up to 10 years, rising to almost 20% after 20 years, with kidney disease and tamoxifen as major risk factors. It advises an eye examination at the start and yearly screening from 5 years onward for people without major risk factors. Retinal damage is not reversible, which is why screening matters, but the guidance also warns against stopping this valuable medicine because of an unconfirmed result.
Lupus medicine questions are rarely simple, because the answer depends on the organ involved, the rest of the treatment and which guideline or label you read. Ask AskMed whether belimumab or anifrolumab is used for lupus nephritis, why EULAR keeps hydroxychloroquine going even when lupus is quiet, or which eye checks the guidance recommends after five years of treatment, and the answer links the EULAR recommendation, the FDA label section or the study each statement comes from. Take what you find to your rheumatologist rather than changing a medicine on your own.
Look up a lupus medicine in AskMed:
Can you get pregnant if you have lupus?
Most babies born to mothers with lupus are healthy, the Lupus Foundation of America says, but pregnancy needs planning, because lupus raises the risk of complications for both mother and baby. The 2020 American College of Rheumatology reproductive health guideline rests on three principles: reliable contraception to prevent unplanned pregnancy, counselling before pregnancy so that conception happens while the disease is quiet and on medicines that are compatible with pregnancy, and close teamwork between the rheumatologist and the obstetric team. The Lupus Foundation of America advises talking to your doctor 3 to 6 months before you start trying, since some medicines stay in the body for months and may need to be switched. It lists higher risks of preeclampsia and HELLP syndrome, flares, miscarriage, stillbirth, preterm birth, blood clots, kidney problems, high blood pressure and slow growth of the baby, and notes that aspirin may lower the risk of preeclampsia. Hydroxychloroquine is considered safe in pregnancy, while methotrexate can cause serious birth defects.
- Medicines to plan around: the FDA label for mycophenolate carries a boxed warning for first-trimester pregnancy loss and birth defects, and advises counselling on pregnancy prevention and planning.
- Anti-Ro/SSA and anti-La/SSB antibodies: doctors test for them because they can cause neonatal lupus. The Lupus Foundation of America puts the risk of congenital heart block in babies of mothers with anti-Ro antibodies at about 2%, about nine times higher after a previously affected pregnancy, and notes that a 2020 study found hydroxychloroquine roughly halved the chance of it happening again. The baby's heart may be checked by ultrasound.
- During and after pregnancy: care with a maternal-fetal medicine specialist, every prenatal visit with blood and urine tests, birth in a hospital with a neonatal intensive care unit, and a rheumatology check 2 to 3 months after delivery.
Get help right away for signs of preeclampsia: blurred or changed vision, a severe headache, severe pain in the upper abdomen, usually under the right ribs, or trouble breathing. If you are not ready to become pregnant, ask which contraception suits you, especially if you have antiphospholipid antibodies.
Living with lupus, and when to seek urgent care
Living with lupus means long-term care with regular check-ups, and the outlook has improved: the American College of Rheumatology says most people with lupus can live normal lives and are living longer than before. The basics are taking medicines as prescribed, even when you feel well, and seeing your rheumatologist regularly. The NHS describes regular blood tests for anemia and urine tests for kidney problems once lupus is confirmed, and the American College of Rheumatology adds blood tests for markers of active disease and kidney function. Sun protection is part of treatment: the NHS advises a high-factor sunscreen of at least factor 50 and a hat outdoors, and the ACR adds protective clothing. Exercise keeps joints flexible and may help prevent heart disease and stroke, according to the ACR. Not smoking, a balanced diet that includes vitamin D and calcium, pacing yourself and asking for help are all in the NHS self-care advice. People on hydroxychloroquine also need the eye checks described above.
Lupus can turn serious quickly, and infections in particular need attention: the authors of the 2019 criteria point out that infections are a major cause of death in SLE and must be suspected first when someone with lupus has a fever. Call emergency services or go to an emergency department for:
- Chest pain or shortness of breath, which can mean inflammation around the heart or lungs, or a blood clot in the lungs.
- A seizure, sudden confusion, a severe headache, weakness or trouble speaking.
- Fever, chills or feeling very unwell while taking steroids or immunosuppressants, which can be a serious infection.
- A painful, swollen leg, a possible blood clot, especially if you have antiphospholipid antibodies.
- Signs of preeclampsia in pregnancy: vision changes, a severe headache, upper abdominal pain or trouble breathing.
Contact your rheumatologist soon, the same day if you can, for foamy urine, new swelling of the legs or around the eyes, much less urine than usual, unusual bruising or bleeding, or a flare that is clearly worse than your usual ones. If you have never been diagnosed but often get symptoms such as joint pain, a rash after sun exposure and tiredness that rest does not fix, the NHS advises seeing your doctor, because early diagnosis and treatment make lupus easier to manage.
Frequently asked questions
Is lupus contagious?
No. Lupus is an autoimmune condition, in which the immune system attacks healthy parts of the body, and the NHS confirms it cannot be caught from or passed to another person. Neonatal lupus comes from maternal antibodies that cross the placenta, not from an infection.
Can you have a positive ANA without lupus?
Yes, very often. A US national survey found a positive ANA in 13.8% of people aged 12 and older, more than 32 million people, and most of them do not have lupus. ANA is useful because a negative result makes SLE unlikely; a positive result needs more specific tests and a clinical assessment.
Is there a cure for lupus?
Not yet. The CDC and MedlinePlus say there is no cure, but lupus can be treated and controlled with medicines and lifestyle changes. Hydroxychloroquine, steroids, immunosuppressants and biologics such as belimumab and anifrolumab are used to calm the disease, prevent flares and protect the organs.
What does a lupus rash look like?
The classic rash is red and butterfly-shaped, spreading across the cheeks and the bridge of the nose, and it often appears after sun exposure. Cutaneous lupus can also cause ring-shaped or scaly patches on sun-exposed skin, or discoid patches that can scar and cause patchy hair loss on the scalp.
Can men get lupus?
Yes, though much less often. In the CDC registry analysis, SLE affected 14.6 men per 100,000 compared with 128.7 women per 100,000. NIDDK notes that lupus nephritis is more common in men with lupus than in women with lupus, so kidney checks matter for them too.
Is lupus hereditary?
Genes raise the risk but do not decide it. The Lupus Foundation of America says about 20% of people with lupus have a parent or sibling who has or may develop it, and about 5% of children of people with lupus develop it. The CDC notes that most people with lupus have no relative with the disease.
Sources
- Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151-1159. Also published in Arthritis Rheumatol. 2019;71(9):1400-1412, full text.
- Aringer M, Leuchten N, Johnson SR. New Criteria for Lupus. Curr Rheumatol Rep. 2020;22(6):18.
- Fanouriakis A, Kostopoulou M, Andersen J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15-29.
- Izmirly PM, Parton H, Wang L, et al. Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis Rheumatol. 2021;73(6):991-996.
- Satoh M, Chan EK, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum. 2012;64(7):2319-2327.
- Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2020;72(4):529-556.
- Marmor MF, Kellner U, Lai TY, et al. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology. 2016;123(6):1386-1394.
- US Food and Drug Administration prescribing information: Benlysta (belimumab), Saphnelo (anifrolumab) and mycophenolate mofetil, via DailyMed.
- American College of Rheumatology. Lupus (patient fact sheet).
- Centers for Disease Control and Prevention. About Lupus and Signs and Symptoms of Lupus. May 2024.
- MedlinePlus. Lupus and Drug-induced lupus erythematosus. US National Library of Medicine.
- National Institute of Diabetes and Digestive and Kidney Diseases. Lupus Nephritis.
- NHS. Lupus. Last reviewed 19 July 2023.
- Lupus Foundation of America. Lupus facts and statistics, Lupus and pregnancy, Understanding lupus environmental triggers and Hydroxychloroquine reduces low heartbeat condition in newborns (2020).
